The stock is still priced like a distressed biotech, but the deal structure (institutional-backed financing + merger) should re-rate it toward Phase 3 execution value. Key Risk: The CRPS-1 Phase 3 ...
Werewolf Therapeutics’ hunt for strategic alternatives has ended.  | Werewolf Therapeutics’ hunt for strategic alternatives has ended. Ambros Therapeutics has agreed to merge with Werewolf in an ...
Got gadgets with barrel jacks? The VFLEX can probably USB-C them. Got gadgets with barrel jacks? The VFLEX can probably USB-C them. is a senior editor and founding member of The Verge who covers ...
Alexandre Aja, who directed the initial 2019 horror thriller, is back in the director's chair for the follow-up. By Borys Kit Senior Film Writer Alexandre Aja, who directed the initial movie, is back ...
In so many transformations I’ve advised, the same scene plays out. The CEO opens the all-hands meeting with conviction: “We are going to become more agile, more digital, more customer-obsessed.” The ...
IN THIS MOMENT, the Grammy Award-nominated, multi-platinum heavy alternative force of nature, returns today with a new single and music video titled "Crawl". Watch the music video below. The track ...
“I have an awful lot of hair,” Lalit Patidar said with a laugh in PEOPLE’s exclusive clip from ‘Most Extreme Humans’ Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the ...
The Middle English Gothic period film opens in theaters starting Christmas Day, and co-stars "Nosferatu" cast members Lily Rose-Depp and Willem Dafoe. Robert Eggers is once again wreaking Gothic ...
SOUTH HADLEY — Whether you walk into Odyssey Bookshop in South Hadley or Rumspringa Books in downtown Springfield, you’ll see that each independent store in the Pioneer Valley is different from the ...
The World of Darkness is eating well next year, as Nacon has revealed a brand new Werewolf The Apocalypse action game called Rageborn. Lauren Bergin News Editor Lauren spends most of her time dead in ...
With its cash cache set to run out by the fourth quarter of this year, Werewolf Therapeutics is prowling the biotech landscape for a deal to keep its pipeline afloat. The immuno-oncology outfit is ...